Bulky stage Ib and II squamous cell carcinoma of the uterine cervix treated by combined preoperative radiation therapy and surgery

被引:0
|
作者
Touboul, E [1 ]
Lefranc, JP [1 ]
Belkacemi, Y [1 ]
Rogel, A [1 ]
Deluen, F [1 ]
Blondon, J [1 ]
Housset, M [1 ]
机构
[1] Hop Tenon, Serv Oncol Radiotherapie, Ctr Tumeurs, F-75020 Paris, France
来源
CONTRACEPTION FERTILITE SEXUALITE | 1998年 / 26卷 / 09期
关键词
bulky squamous cell carcinoma of the uterine cervix; prognostic factors; combination therapy; radiation therapy; chemotherapy; surgery; para-aortic lymph; node control;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Fifty-two women with stage Ib2 and II bulky squamous cell carcinoma of the uterine cervix (mean size : 5,65 +/- 0, 12 cm, range : 5-8 cm) were treated between July 1982 and December 1993. The median follow-up was 73 months. Their patient's age ranged from 25 to 77 years (median : 45 years). There were 18 stage Ib2, 8 stage IIa and 26 stage IIb operable patients. External radiotherapy was delivered using photons of 6 MV to 25 MV and a four-field <<box>> technique (upper limit situated between L4-L5). Mean total dose at mid-plane to the whole pelvis was 38.6 Gy (range : 37.4-40.6 Gy) in 18 fractions over 30 days. A boost dose of 20 Gy was given by intracavitary brachytherapy (utero-vaginal). After a mean rest of 48 days, total abdominal hysterectomy and bilateral salpingo-oophorectomy combined with bilateral pelvic lymphadenectomy was performed. Following surgery no remaining tumor on pathological examination of uterine cervix was observed in 39 cases (75 %) and positive external iliac nodes were found in 4 cases. Five- and 10-year specific survival rates were 80 % and 75 %, respectively. The 5-year local tumour recurrence and nodal recurrence rates were 18 % and 15 %, respectively There were 7 para-aortic nodal recurrences (3 were isolated para-aortic nodal relapses). There were five late severe complications necessiting surgical intervention. A combination of preoperative radiation therapy and concomitant chemotherapy and the extended dissection of common iliac and para-aortic lymph nodes or a post operative prophylactic extended field irradiation including para-aortic lymph nodes is now being attempted in order to improve the locoregional tumour and para-aortic lymph node control rates.
引用
收藏
页码:674 / 685
页数:12
相关论文
共 50 条
  • [41] Phase II study of vincristine, bleomycin, mitomycin C and cisplatin (VBMP) in disseminated squamous cell carcinoma of the uterine cervix
    Vermorken, JB
    Mangioni, C
    Pecorelli, S
    Van Der Burg, MEL
    Van Oosterom, AT
    Huinink, WWT
    Rotmensz, N
    Dalesio, O
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2000, 10 (05) : 358 - 365
  • [42] Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervix
    Shimada, Muneaki
    Nagao, Shoji
    Fujiwara, Keiichi
    Takeshima, Nobuhiro
    Takizawa, Ken
    Shoji, Tadahiro
    Sugiyama, Toru
    Yamaguchi, Satoshi
    Nishimura, Ryuichiro
    Kigawa, Junzo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (06) : 1128 - 1135
  • [43] Adjuvant Radiation Therapy Increases Disease-Free Survival in Stage IB Merkel Cell Carcinoma
    Sexton, Kevin W.
    Poteet, Stephen P.
    Hill, John Bradford
    Schmidt, Alexandra
    Patel, Ashit
    Del Corral, Gabriel A.
    Axt, Jason
    Kelley, Mark C.
    Thayer, Wesley P.
    Shack, Robert Bruce
    ANNALS OF PLASTIC SURGERY, 2014, 73 (05) : 531 - 534
  • [44] Incidence and predictors of toxicity in the management of vulvar squamous cell carcinoma treated with radiation therapy
    McCall, Neal S.
    Eng, Tony Y.
    Shelton, Joseph W.
    Hanasoge, Sheela
    Patel, Pretesh R.
    Patel Jr, Ashish B.
    McCook-Veal, Ashley A.
    Switchenko, Jeffrey M.
    Cole, Tonya E.
    Khanna, Namita
    Han, Chanhee H.
    Gordon, Alan N.
    Starbuck, Kristen D.
    Remick, Jill S.
    GYNECOLOGIC ONCOLOGY REPORTS, 2022, 44
  • [45] A PHASE-II STUDY OF IFOSFAMIDE, CARBOPLATIN AND CISPLATIN IN ADVANCED AND RECURRENT SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX
    FILTENBORG, TA
    HANSEN, HH
    ENGELHOLM, SA
    RORTH, M
    ANNALS OF ONCOLOGY, 1993, 4 (06) : 485 - 488
  • [46] Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: Indications for surgery or combined chemoradiotherapy
    Ishikawa, Hitoshi
    Sakurai, Hideyuki
    Tamaki, Yoshio
    Nonaka, Tetsuo
    Yamakawa, Michitaka
    Saito, Yoshihiro
    Kitamoto, Yoshizumi
    Higuchi, Keiko
    Hasegawa, Masatoshi
    Nakano, Takashi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (08) : 1290 - 1296
  • [47] Clinical factor-based risk stratification for precision therapy in locally advanced squamous cell carcinoma of the uterine cervix
    Liu, Feng-Yuan
    Chen, Wei-Chun
    Pan, Yu-Bin
    Wang, Chun-Chieh
    Tang, Yun-Hsin
    Chou, Hung-Hsueh
    Chao, Angel
    Yang, Lan-Yan
    Lai, Chyong-Huey
    CANCER MEDICINE, 2024, 13 (01):
  • [48] Evaluating delays in patients treated with post-operative radiation therapy for head and neck squamous cell carcinoma
    Marwah, Ravi
    Goonetilleke, Daniel
    Smith, Justin
    Chilkuri, Madhavi
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2022, 66 (06) : 840 - 846
  • [49] Treatment results of preoperative concurrent chemoradiotherapy followed by surgery for stage III or IV esophageal squamous cell carcinoma
    Yamashita H.
    Nakagawa K.
    Tago M.
    Nakamura N.
    Shiraishi K.
    Mafune K.-I.
    Kaminishi M.
    Ohtomo K.
    Radiation Medicine, 2006, 24 (1): : 65 - 71
  • [50] Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix
    van Luijk, I. F.
    Coens, C.
    van der Burg, M. E. L.
    Kobierska, A.
    Namer, M.
    Lhomme, C.
    Zola, P.
    Zanetta, G.
    Vermorken, J. B.
    ANNALS OF ONCOLOGY, 2007, 18 (02) : 275 - 281